Buller Alex J, Morgan Laurence H, Hercules Brian L
Stepping Hill Hospital, Poplar Grove, Stockport, Cheshire, UK.
Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):293-4. doi: 10.1007/s00417-006-0333-3.
The relationship between complexity of eye drop regime and compliance is not straightforward, i.e. fewer drops may not mean better compliance. We investigated the level of inconvenience different eye drop regimes incurred in comparison with a once-daily (OD) regime for patients experienced with using topical anti-glaucoma medication.
Patients indicated the level of inconvenience from drop regimes of 1, 2, 3 or 4 times daily on 10-cm visual analogue scales. The score for the OD regime was then compared with the scores for the other regimes using paired t-tests with Bonferroni correction.
At a significance limit of p = 0.05, five of six subgroups indicated once-a-day drops were significantly more convenient than other regimes. Patients who had used the OD regime considered this difference greater than those who had not.
This study's results offer some pragmatic guidance on choice of therapy and on counselling patients about compliance. We would suggest starting patients on OD drops in preference to alternatives to promote compliance.
眼药水用药方案的复杂性与依从性之间的关系并非简单直接,也就是说,滴数较少并不意味着依从性更好。我们针对有使用局部抗青光眼药物经验的患者,调查了不同眼药水用药方案相较于每日一次(OD)方案所带来的不便程度。
患者在10厘米视觉模拟量表上指出每日1次、2次、3次或4次用药方案带来的不便程度。然后使用经邦费罗尼校正的配对t检验,将OD方案的得分与其他方案的得分进行比较。
在显著性水平p = 0.05时,六个亚组中有五个表明每日一次滴眼明显比其他方案更方便。使用过OD方案的患者认为这种差异比未使用过的患者更大。
本研究结果为治疗选择以及就依从性向患者提供咨询提供了一些实用指导。我们建议优先让患者开始使用每日一次的眼药水,而非其他方案,以提高依从性。